Blogs about: Preclinical
Featured Blog
Pfizer have published a series of PYK2 inhibitors
Pfizer have published a series of trifluoromethylpyrimidine proline-rich tyrosine kinase 2 (PYK2) inhibitors… more →
Kinase News
In vivo models for disease
4visionmarketing wrote 2 weeks ago: Our partner has available a broad range of in vivo preclinical models in: - Infectious disease - Int … more →
What the average day is like.
— 1 comment
Ang wrote 9 months ago: Hey, Far too bored to continue making notes on Pharmacology at the moment, so am taking a short brea … more →
Additional Positive Findings For APOPTONE (HE3235) In Preclinical Models Of Castration-Resistant Prostate Cancer
healtherm2 wrote 10 months ago: Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today presented new findings that suggest APOPTONE … more →
Bioheart Reports Promising Results From Preclinical Study Of Adipose Derived Acute Cell Therapy
healtherm2 wrote 10 months ago: A preclinical study involving the injection of adipose-derived stem cells (ADSCs) into the myocardiu … more →
Eisai publish series of BK Channel-Opening Agents
crimsoncanary wrote 1 year ago: Eisai have published a series of Oxime and Oxime Ether 12,14-Dichlorodehydroabietic Acid derivative … more →
NeurogesX Submit NDA for NGX-4010 for Treatment of Postherpetic Neuralgia (PHN)
crimsoncanary wrote 1 year ago: NeurogesX have submitted a new drug application (NDA) with the U.S. FDAS for NGX-4010 Dermal Capsaic … more →
Pfizer have published a series of PYK2 inhibitors
crimsoncanary wrote 1 year ago: Pfizer have published a series of trifluoromethylpyrimidine proline-rich tyrosine kinase 2 (PYK2) in … more →
Novartis publish series of MK2 inhibitors
crimsoncanary wrote 1 year ago: Novartis have published a series of pyrrolo-pyrimidone MK2 Inhibitors … more →
J&J indentify new JAK3 inhibitors
crimsoncanary wrote 1 year ago: J&J have published a series of Janus kinase 3 (JAK3) inhibitors … more →
Pfizer publish series of MEK inhibitors
crimsoncanary wrote 1 year ago: Pfizer have publsihed a series of MEK (MAP ERK Kinase) inhibitors. … more →
Vertex publish series of Syk kinase inhibitors
crimsoncanary wrote 1 year ago: Vertex have published a series of 4-Thiazolyl-2-phenylaminopyrimidine Spleen Tyrosine Kinase (SYK) i … more →
Wyeth publish series of 5-HT1A Receptor/5-HT transporter inhibiors
crimsoncanary wrote 1 year ago: Wyeth have published a series of dual 5-HT1A /5-HT transporter inhibitors … more →
Scripps Inst publish series of Rho kinase II inhibitors
crimsoncanary wrote 1 year ago: Researchers from the Scripps Inst have published a series of Rho kinase 2 inhibitors. One compound h … more →
Vorinostat enhances MK-0457 activity in AML/CML
crimsoncanary wrote 1 year ago: Vorinostat has been found to enhance the activity of Aurora kinase inhibitor MK-0457 (VX-680) on cul … more →
Sunesis publish modified SNS-032 analogs
crimsoncanary wrote 1 year ago: Sunesis have published a series of modified SNS-032 analogs … more →
Boehringer Ingelheim publish series of ITK inhibitors
crimsoncanary wrote 1 year ago: Boehringer Ingelheim have published a series of 2-Aminobenzimidazole ITK inhibitors … more →
GSK publish series of PLK-1 inhibitors
crimsoncanary wrote 1 year ago: GSK have published a seies of Imidazo[5,1-f][1,2,4]triazin-2-amine polo-like kinase 1inhibitors … more →
Actelion publish series of orexin 1/ orexin 2 receptor antagonists
crimsoncanary wrote 1 year ago: Actelion have published a series of N-glycine-sulfonamides as potent dual orexin 1/ orexin 2 recepto … more →
AstraZeneca publish series of EphB4 inhibitors
crimsoncanary wrote 1 year ago: AstraZeneca have published a series of 3,5-bis substituted anilinopyrimidine EphB4 inhibitors … more →
